Market Tracker

02/23 5:16pm ET

Repligen Corp (NASDAQ:RGEN)

32.40
Delayed Data
As of Feb 23
 +0.08 / +0.25%
Today’s Change
21.11
Today|||52-Week Range
34.06
+5.13%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close32.32
Today’s open32.45
Day’s range31.67 - 32.66
Volume300,362
Average volume (3 months)238,849
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+55.95%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio162.0
Price/Sales11.37
Price/Book8.68

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...+0.15+0.69%
LOXOLoxo Oncology Inc+0.22+0.52%
EGRXEagle Pharmaceutical...+3.27+4.53%
TXMDTherapeuticsMD Inc-0.03-0.53%
Data as of 4:00pm ET, 02/23/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.14
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts